| TTM
|
12/31/2025
|
12/31/2024
|
12/31/2023
|
12/31/2022
|
|
|---|---|---|---|---|---|
| Total Revenue
|
0 | 0 | 0 | 0 | 0 |
| Selling, General and Administrative Expenses
|
-3,502.0610 | -3,731.7340 | -3,096.2170 | -1,732.0850 | -2,024.6240 |
|
Research and Development Expenses
|
-1,078.7530 | -1,897.2760 | -2,050.6630 | -1,749.2400 | -2,389.3600 |
| Depreciation, Amortization and Depletion
|
-1.8630 | -1.8630 | -1.8630 | -1.8620 | -3.4370 |
| Other Income/Expense, Operating
|
0 | 336.1080 | 617.1400 | 557.7100 | 989.0420 |
|
Operating Income/Expenses
|
-4,582.6770 | -5,294.7650 | -4,531.6030 | -2,925.4770 | -3,428.3790 |
|
Total Operating Profit/Loss
|
-4,582.6770 | -5,294.7650 | -4,531.6030 | -2,925.4770 | -3,428.3790 |
| Total Net Finance Income/Expense
|
-198.7100 | -210.3590 | -239.0730 | -216.2140 | -163.6910 |
| Net Investment Income
|
0 | 0 | -0.7910 | 24.2270 | 0.4330 |
| Irregular Income/Expenses
|
-- | -- | -- | -- | 0 |
|
Other Income/Expense, Non-Operating
|
0.2810 | 0 | 9.3200 | 15.6960 | 36.9540 |
|
Non-Operating Income/Expenses, Total
|
-198.4290 | -210.3590 | -230.5440 | -176.2910 | -126.3040 |
|
Pretax Income
|
-4,781.1060 | -5,505.1240 | -4,762.1470 | -3,101.7680 | -3,554.6830 |
|
Net Income from Continuing Operations
|
-4,781.1060 | -5,505.1240 | -4,762.1470 | -3,101.7680 | -3,554.6830 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
-4,781.1060 | -5,505.1240 | -4,762.1470 | -3,101.7680 | -3,554.6830 |
|
Non-Controlling/Minority Interests
|
28.9930 | -- | -- | -- | -- |
|
Net Income after Non-Controlling/Minority Interests
|
-4,823.6160 | -5,505.1240 | -4,762.1370 | -3,101.7680 | -3,554.6830 |
|
Net Income Available to Common Stockholders
|
-4,823.6160 | -5,505.1240 | -4,762.1370 | -3,101.7680 | -3,554.6830 |
|
Diluted Net Income Available to Common Stockholders
|
-4,823.6160 | -5,505.1240 | -4,762.1370 | -3,101.7680 | -3,554.6830 |
| Basic EPS
|
-0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| Diluted EPS
|
-0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
|
Basic Weighted Average Shares Outstanding
|
420,279.8790 | 420,279.8790 | 419,810.0590 | 419,508.1460 | 419,470.3380 |
|
Diluted Weighted Average Shares Outstanding
|
420,279.8790 | 420,279.8790 | 419,810.0590 | 419,508.1460 | 419,470.3380 |
| Income Statement, Supplemental
|
|||||
|
EBIT
|
-4,582.3960 | -5,294.7650 | -4,523.0740 | -2,885.5540 | -3,390.9920 |
|
EBITDA
|
-4,580.5330 | -5,292.9020 | -4,515.9170 | -2,876.6330 | -3,380.0970 |
|
Normalized EBITDA
|
-3,368.1620 | -4,055.3560 | -3,235.1410 | -2,873.7830 | -3,377.0720 |
|
Normalized Income
|
-3,568.7350 | -4,267.5780 | -3,481.3710 | -3,098.9180 | -3,551.6580 |
|
Total Unusual Items
|
1,212.3710 | 1,237.5460 | 1,280.7760 | 2.8500 | 3.0250 |
|
Total Unusual Items Excluding Goodwill
|
1,212.3710 | 1,237.5460 | 1,280.7760 | 2.8500 | 3.0250 |
12/31/2022 - 1/15/1997
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade